Clinical Trial Update: Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration

View source ↗

Summary

A clinical trial evaluating the effectiveness of Eylea (aflibercept) in wet age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Wet Age-related Macular Degeneration | Status: COMPLETED